Technology | Remote Viewing Systems | May 31, 2017

MIM Software Inc. Announces Updates to MIM Encore

Nuclear imaging viewer now offers enhanced display management tools, dedicated reports and new dictation software integration

May 31, 2017 — MIM Software Inc. recently announced significant updates to its MIM Encore solution for viewing nuclear medicine images. The vendor-neutral application offers viewing of positron emission tomography (PET)/computed tomography (CT), single photon emission computed tomography (SPECT)/CT, PET/magnetic resonance imaging (MRI) and general nuclear medicine images. Physicians and technologists can streamline the nuclear medicine workflow by viewing and processing images in tandem using this single-platform solution.

The update includes various enhancements and new features such as:

Enhanced display management tools for quick swapping of a number of follow-up exams;
Dedicated reports for tracking each patient's findings for referrers;
A new dictation software integration focused on transferring findings statistics to reports;
New contouring tools, and more.

MIM Software will be demonstrating MIM Encore at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, June 10-13 in Denver.

For more information: www.mimsoftware.com

Related Content

Videos | Artificial Intelligence | September 25, 2020

VIDEO: Use of Artificial Intelligence in Nuclear Imaging

Ernest Garcia, Ph.D.,

Lung and respiratory health pioneer paves way for more precise care of complex respiratory conditions

News | Artificial Intelligence | September 25, 2020

VIDA Receives FDA Clearance for Deep Learning-based Enhancements to LungPrint Solution

September 25, 2020 — VIDA Diagnostics, Inc. announced that it has received 510(k) clearance from the Food and Drug Ad

Of all the buzzwords one would have guessed would dominate 2020, few expected it to be “virtual”. We have been virtualizing various aspects of our lives for many years, but the circumstances of this one has moved almost all of our lives into the virtual realm.

Getty Images

Feature | Radiology Education | September 18, 2020 | By Jef Williams

Extracting Value From Virtual Events

Of all the buzzwords one would have guessed would dominate 2020, few expected it to be “virtual”.

Indeterminate lesion on PET/CT classified by PET/MRI for 53-y-old man with lung cancer.

Indeterminate lesion on PET/CT classified by PET/MRI for 53-y-old man with lung cancer. Contrast-enhanced CT (A), PET (B), and fused 18F-FDG PET/CT (C) images are displayed in comparison with contrast-enhanced T1-weighted MRI (D), PET, and fused 18F-FDG PET/MRI (F) images. In CT (A), hyperdense, subcentimeter liver lesion (arrows) in segment VII is suggestive of transient hepatic attenuation difference or small hemangioma. As malignancy cannot be excluded, it needs further investigation. On PET/MRI, lesion is clearly classified as metastasis because of contrast enhancement and tracer uptake due to later acquisition time point. Follow-up CT confirmed diagnosis after 78 d. Images created by Ole Martin, University Dusseldorf, Medical Faculty and Benedikt Schaarschmidt, University Hospital Essen.

News | PET-MRI | September 18, 2020

PET/MRI Improves Lesion Detection, Reduces Radiation Exposure

September 18, 2020 — A single-center observational study of more than 1,000 oncological examinations has demonstrated